Free Access
| Issue |
Med Sci (Paris)
Volume 21, Décembre 2005
Métabolisme glucidolipidique et risque cardiovasculaire: Nouvelle approches
|
|
|---|---|---|
| Page(s) | 23 - 25 | |
| Section | M/S revues | |
| DOI | https://doi.org/10.1051/medsci/20052111s23 | |
| Published online | 15 November 2005 | |
- Thadhani R, Wolf M, West ML, et al. Patients with Fabry disease on dialysis in the United States. Kidney Int 2002; 61 : 249–55. [Google Scholar]
- Branton MH, Schiffmann R, Sabnis SG, et al. Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course. Medicine (Baltimore) 2002; 81 : 122–38. [Google Scholar]
- Gubler MC, Lenoir G, Grünfeld JP, et al. Early renal changes in hemizygous and heterozygous patients with Fabry’s disease. Kidney Int 1978; 13 : 223–35. [Google Scholar]
- Grünfeld JP, Le Porrier M, Droz D, et al. La transplantation rénale chez les sujets atteints de maladie de Fabry. Nouv Presse Med 1975; 29 : 2081–5. [Google Scholar]
- Ojo A, Meier-Kriesche HU, Friedman G, et al. Excellent outcome of renal transplantation in patients with Fabry’s disease. Transplantation 2000; 69 : 2337–9. [Google Scholar]
- Thurberg BL, Rennke H, Robert B, et al. Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy. Kidney Int 2002; 62 : 1933–46. [Google Scholar]
- Wilcox WR, Banikazemi M, Guffon N, et al. Long-term safty and efficacy on enzyme replacement therapy for Fabry disease. Am J Hum Genet 2004; 75 : 65–74. [Google Scholar]
- De Schoenmakere G, Chauveau D, Grünfeld JP. Enzyme replacement therapy in Anderson-Fabry’s disease: beneficial clinical effect on vital organ function. Nephrol Dial Transplant 2003; 18 : 33–5. [Google Scholar]
- Kosch M, Koch HG, Oliveira JP, et al. Enzyme replacement therapy administered during hemodialysis in patients with Fabry disease. Kidney Int 2004; 66 : 1279–82. [Google Scholar]
- Mignani R, Panichi V, Giudicissi A, et al. Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: a pilot study. Kidney Int 2004; 65 : 1381–5. [Google Scholar]
- Brenner BM, Grünfeld JP. Renoprotection by enzyme replacement therapy. Curr Opin Nephrol Hypertens 2004; 13 : 231–41. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.